Efficacy and Safety of Ixekizumab for the Treatment of Plaque Psoriasis: Results through 108 Weeks Randomised, Phase III Clinical Trial (UNCOVER-3)
Martin Dossenbach (non author presenter)
0 views
0 downloads
Powered by
Discover more research and events on morressier.com